DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more.

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

FEBRUARY 6, 2024

EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. By guiding ablation therapy, [EGF mapping] can enable clinicians to provide personalized, highly targeted treatment."

Ablation 104

Ablation Atrial Fibrillation AFIB Pulmonary 104

HeartRhythm

DECEMBER 31, 2024

The development of electrophysiology (EP) studies through intravascular catheters provided the leap to verifying mechanisms, setting the stage for interventions. The contemporaneous evolution of cardiac surgery permitted direct access to the heart to modify arrhythmia substrate.

Arrhythmia 45

Arrhythmia Bradycardia Electrocardiogram Electrophysiology 45

DAIC

DECEMBER 14, 2023

Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

DAIC

JANUARY 18, 2024

milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib).

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

Journal of Cardiovascular Electrophysiology

JANUARY 17, 2025

Atypical AFL is a heterogenous group of re-entrant atrial tachycardias that most commonly occur in patients with prior heart surgery or catheter ablation. AFL is difficult to manage medically and catheter ablation is the preferred treatment for most patients.

Atrial Flutter 40

Atrial Flutter Electrophysiology Ablation Tachycardia 40

American College of Cardiology

FEBRUARY 12, 2025

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.

Atrial Fibrillation 60

Atrial Fibrillation Ablation AFIB Electrophysiology 60

HeartRhythm

FEBRUARY 17, 2025

Electroanatomic mapping (EM) has revolutionized the understanding and ablation of complex arrhythmias by providing simultaneous representation of electrogram timing, location, and voltage in both space and time. In this editorial we will review mapping and ablation of APs, and it is divided into two parts.

Electrophysiology 40

Electrophysiology Ablation Laboratory Technology 40

DAIC

JUNE 11, 2024

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace. So, again, innovation is great.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

HeartRhythm

APRIL 30, 2024

Ablation in VT in patients with electrical storm (ES) is challenging and associated with increased peri-procedural morbidity and mortality. The implications of ES on electrophysiological characteristics are not well understood.

Electrophysiology 40

Electrophysiology Ablation Tachycardia Outcomes 40

DAIC

OCTOBER 21, 2024

FDA approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance for the new FARAVIEW Software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation System.

Ablation 59

Ablation Atrial Fibrillation Technology Electrophysiology 59

Dr. Smith's ECG Blog

JANUARY 9, 2024

Medical treatment for heart failure was optimized and after a few days the patient was discharged with referral to VT ablation procedure. After atrial rhythm/SR was restored the patient slowly improved. Learning points *A patient with tachydysrhythmia and chest discomfort needs immediate rhythm or rate control.

Tachycardia 120

Tachycardia Electrophysiology Atrial Flutter Ischemia 120

HeartRhythm

APRIL 30, 2024

There is limited data regarding safety, electrophysiologic characteristics and arrhythmia substrate during ventricular tachycardia (VT) ablation in patients with prior aortic valve replacement (AVR).

Aortic valve 40

Aortic valve Electrophysiology Tachycardia Aortic 40

Dr. Smith's ECG Blog

MAY 7, 2024

Electrophysiology note : "In the context of pre-excited atrial fibrillation, we would recommend proceeding with mapping and ablation of accessory pathway (particularly given high risk features including his shortest pre-excited R-R interval is 25 X6 = 150/minute ). Pre-excitation results in a short PR interval.

Atrial Fibrillation 131

Atrial Fibrillation AFIB Ablation Chest Pain 131

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Despite the relative efficacy of ablation, the risk of AF recurrence is substantial, particularly in patients with persistent AF (perAF). At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation.

Pulmonary 64

Pulmonary Ablation Atrial Fibrillation Electrophysiology 64

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

HeartRhythm

AUGUST 4, 2024

Despite their improved safety, by and large, cardiac electrophysiology procedures including catheter ablation (CA), are presently performed in hospital outpatient departments.

Electrophysiology 40

Electrophysiology Outpatient Ablation Hospital 40

Journal of the American Heart Association

DECEMBER 8, 2023

Twenty‐six PVT/ventricular fibrillation–triggering PVCs were identified for ablation. After a mean follow‐up of 49 months after ablation, 8 (57%) patients were free from syncope recurrence. Ablation of trigger beat significantly reduced the syncope frequency (mean±SD, 4.3±1.6

Ablation 45

Ablation Tachycardia Electrophysiology Outcomes 45

HeartRhythm

MAY 8, 2024

Establishing the precise mechanism of cardiac arrhythmias in the electrophysiology laboratory is one of the main requisites for a successful and safe ablation.

Electrophysiology 40

Electrophysiology Laboratory Article Tachycardia 40

American College of Cardiology

APRIL 24, 2024

The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.

Atrial Fibrillation 63

Atrial Fibrillation Heart Failure Electrophysiology Ablation 63

HeartRhythm

APRIL 5, 2024

Hence, the electrophysiological and ablation target characteristics are poorly described. The aorta-mitral annulus conjunction (AMC) is uncommon site of origin of focal atrial tachycardias (AT).

Electrophysiology 40

Electrophysiology Bicuspid/Mitral Tachycardia Ablation 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 18, 2024

Five criteria predict whether patients are likely or unlikely to have supraventricular tachycardia induced or ablated at an electrophysiologic study (EPS). Methods We performed a retrospective chart review of 1089 patients referred for EPS and ablation of SVT at 2 high volume centers. 001; Ablation, 88% versus 26%, RR = 3.32 (2.48–4.46),

Tachycardia 45

Tachycardia Ablation Electrophysiology Article 45

Journal of Cardiovascular Electrophysiology

DECEMBER 11, 2024

HPSD CTI ablation performed by EP trainees demonstrated a higher first-pass bidirectional isthmus block compared to the MPLD method. The aim of this study was to clarify the efficacy and safety of HPSD CTI-Abl performed by EP trainees and assess lesion characteristics between HPSD and moderate-power long duration (MPLD) ablations.

Tricuspid 40

Tricuspid Electrophysiology Ablation Article 40

HeartRhythm

APRIL 30, 2024

Hence, the electrophysiological and ablation target characteristics are poorly described. Focal AT at the aorta-mitral annulus conjunction (AMC) is uncommon.

Electrophysiology 40

Electrophysiology Bicuspid/Mitral Anatomy Tachycardia 40

HeartRhythm

SEPTEMBER 5, 2024

Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.

Congenital Heart Disease 45

Congenital Heart Disease Ablation Congenital Heart Disease 45

CardiacWire

DECEMBER 17, 2023

The AFib pulsed field ablation treatment era officially began in the US last week, following the FDA approval of Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation. PFA systems use electroporation (short electrical pulses) to achieve pulmonary vein isolation.

AFIB 105

AFIB Ablation Atrial Fibrillation Pulmonary 105

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrial fibrillation (PeAF) patients. 0.78, p  = .006).

Atrial Fibrillation 75

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia 75

ADN Center of Excellence

MAY 17, 2024

It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre.

AFIB 59

AFIB Atrial Fibrillation Ablation Heart Rhythm 59

Circulation

JANUARY 6, 2025

BACKGROUND:Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high recurrence rates and long procedure durations. Contrast-enhanced cardiac magnetic resonance images were used to reconstruct finite-element meshes, onto which regional electrophysiological properties were applied.

Tachycardia 85

Tachycardia Ablation Technology Electrophysiology 85

DAIC

JUNE 11, 2024

Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. “As

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

HeartRhythm

APRIL 30, 2024

Atypical Atrial Flutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.

Atrial Flutter 40

Atrial Flutter Ablation Electrophysiology Atrial Fibrillation 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

The standardized workflow included general anesthesia, a single transeptal puncture trough with a bidirectional, steerable visualizable sheath introduced into the left atrium accommodated a high density, penta-spline mapping catheter and a contact force sensor ablation catheter enabled to deliver vHPSD.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Laboratory Electrophysiology 52

HeartRhythm

APRIL 30, 2024

To reduce arrhythmic risk, novel clinical tools must identify patients with rTOF who will benefit from an electrophysiology study (EPS) and SCAI ablation.

Electrophysiology 40

Electrophysiology Ablation Arrhythmia 40